Glaxosmithkline | Biaya Penjualan

Harga Saham
58.93
Perubahan Harian
10.64 22.03%
Bulanan
20.98%
Tahunan
62.93%
Q1 Perkiraan
57.76




Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.55B 757M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Aurora Cannabis CAD 58.08M 11.99M 2025-09
Bausch Health Companies USD 750M 14M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Canopy Growth CAD 44.78M 9.32M 2025-09
Corcept Therapeutics USD 4.6M 1.16M 2025-09
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Glaxosmithkline GBP 3.01B 853.01M 2025-09
J&J USD 7.97B 689M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 217M 2025-09
Pacira USD 48.6M 6.59M 2025-09
Perrigo USD 666.2M 27.2M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Phibro Animal Health USD 207.39M 30.45M 2024-12
Prestige Brands USD 131.22M 3.52M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Supernus Pharmaceuticals USD 43.29M 5.64M 2025-09
Takeda JPY 401.15B 184.07B 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Zoetis USD 743M 60M 2025-12


Glaxosmithkline Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.